Home
Categories
EXPLORE
True Crime
Comedy
Society & Culture
Business
Sports
History
Fiction
About Us
Contact Us
Copyright
© 2024 PodJoint
00:00 / 00:00
Sign in

or

Don't have an account?
Sign up
Forgot password
https://is1-ssl.mzstatic.com/image/thumb/Podcasts126/v4/d5/99/b7/d599b713-ff02-e764-7538-1eddd5205db0/mza_13218934625607905026.jpg/600x600bb.jpg
Fast Five Medtech News Podcast
MassDevice
161 episodes
8 months ago
Welcome to the MassDevice Fast Five medtech news podcast, the show that keeps you up-to-date on the latest breakthroughs in medical technology. Here’s what you need to know for today, March 15, 2024. Check out the show notes for links to the stories we discussed today at MassDevice.com/podcast. Conformal Medical this week reported "encouraging" results for its left atrial appendage occlusion device. Fast Five hosts Danielle Kirsh and Sean Whooley discuss what the device does and what doctors think about the device. Autonomix has completed its first procedures in its pancreatic cancer ablation trial. Learn what the trial will assess, what the technology does and how optimistic executives are. Axonics won CE mark approval for its fourth-generation rechargeable sacral neuromodulation system. Whooley talks about what the device does and some of the other news Axonics has had recently. SafeGuard Surgical won an FDA breakthrough nod for its biodegradable stent. Hear more about the stent, which has backing from an NFL quarterback. Edwards reported "excellent" outcomes with its latest Sapien TAVR study. The Fast Five hosts talk about some of the data points that stuck out.
Show more...
News
RSS
All content for Fast Five Medtech News Podcast is the property of MassDevice and is served directly from their servers with no modification, redirects, or rehosting. The podcast is not affiliated with or endorsed by Podjoint in any way.
Welcome to the MassDevice Fast Five medtech news podcast, the show that keeps you up-to-date on the latest breakthroughs in medical technology. Here’s what you need to know for today, March 15, 2024. Check out the show notes for links to the stories we discussed today at MassDevice.com/podcast. Conformal Medical this week reported "encouraging" results for its left atrial appendage occlusion device. Fast Five hosts Danielle Kirsh and Sean Whooley discuss what the device does and what doctors think about the device. Autonomix has completed its first procedures in its pancreatic cancer ablation trial. Learn what the trial will assess, what the technology does and how optimistic executives are. Axonics won CE mark approval for its fourth-generation rechargeable sacral neuromodulation system. Whooley talks about what the device does and some of the other news Axonics has had recently. SafeGuard Surgical won an FDA breakthrough nod for its biodegradable stent. Hear more about the stent, which has backing from an NFL quarterback. Edwards reported "excellent" outcomes with its latest Sapien TAVR study. The Fast Five hosts talk about some of the data points that stuck out.
Show more...
News
https://i1.sndcdn.com/artworks-eakjTfeQXy8RNvmV-P59pkg-t3000x3000.jpg
Fast Five: FTC may look at Boston Scientific's Axonics buy, Roche unveils new AI-enabled CGM
Fast Five Medtech News Podcast
12 minutes 14 seconds
1 year ago
Fast Five: FTC may look at Boston Scientific's Axonics buy, Roche unveils new AI-enabled CGM
Welcome to the MassDevice Fast Five medtech news podcast, the show that keeps you up-to-date on the latest breakthroughs in medical technology. Here’s what you need to know for today, March 8, 2024. Check out the show notes at MassDevice.com/podcast. Siemens Healthineers launched a new surgical planning tool. Fast Five hosts Chris Newmarker and Sean Whooley examine the latest application of surgical planning and education using the Apple Vision Plus system. Nanoflex Robotics announced the first U.S. installations of its surgical robot. The hosts take a look at what this robot does and how Nanoflex hopes to use it to improve the treatment of stroke patients. Biobot Surgical raised $18 million to support its surgical robot. Newmarker and Whooley break down the unique purpose of this company's surgical robot and discuss the potential uses of proceeds. Roche Diabetes Care unveiled its new CGM technology with predictive AI algorithms. The Fast Five hosts examine the properties of yet another potential competitor in the CGM market and see if the predictive AI capabilities could set it apart from the rest. The FTC is reportedly looking into Boston Scientific’s acquisition of Axonics. Following a $3.7 billion acquisition, some questions have arisen around antitrust activity. Newmarker and Whooley look at Bloomberg's report on a potential investigation and break down the potential fallout if this acquisition doesn't go through.
Fast Five Medtech News Podcast
Welcome to the MassDevice Fast Five medtech news podcast, the show that keeps you up-to-date on the latest breakthroughs in medical technology. Here’s what you need to know for today, March 15, 2024. Check out the show notes for links to the stories we discussed today at MassDevice.com/podcast. Conformal Medical this week reported "encouraging" results for its left atrial appendage occlusion device. Fast Five hosts Danielle Kirsh and Sean Whooley discuss what the device does and what doctors think about the device. Autonomix has completed its first procedures in its pancreatic cancer ablation trial. Learn what the trial will assess, what the technology does and how optimistic executives are. Axonics won CE mark approval for its fourth-generation rechargeable sacral neuromodulation system. Whooley talks about what the device does and some of the other news Axonics has had recently. SafeGuard Surgical won an FDA breakthrough nod for its biodegradable stent. Hear more about the stent, which has backing from an NFL quarterback. Edwards reported "excellent" outcomes with its latest Sapien TAVR study. The Fast Five hosts talk about some of the data points that stuck out.